Brain diseases are now the world's leading source of disability. The fastest growing of these is Parkinson's: the number of impacted patients has doubled to more than six million over the last twenty-five years and is projected to double again by 2040. Harmful pesticides that increase the risk of Parkinson's continue to proliferate, many people remain undiagnosed and untreated, research funding stagnates, and the most effective treatment is now a half century old.
In Ending Parkinson's Disease, four top experts provide a plan to help prevent Parkinson's, improve care and treatment, and end the silence associated with this devastating disease.
|Product dimensions:||6.00(w) x 9.40(h) x 1.20(d)|
About the Author
Todd Sherer, PhD, is the Chief Executive Officer of The Michael J. Fox Foundation for Parkinson's Research, the largest nonprofit funder of Parkinson's research. Trained as a neuroscientist, he is responsible for the Foundation's overall scientific and fundraising direction to speed treatment breakthroughs and a cure for Parkinson's disease. After a postdoctoral fellowship at Emory University investigating the role of environmental factors in Parkinson's, Todd joined the Foundation's staff in 2004 and was named Chief Executive Officer in 2011.
Michael S. Okun is the Chair and the Adelaide Lackner Professor of Neurology at the University of Florida. Michael is one of the world's leading Parkinson's disease researchers who has advanced surgical treatments. Michael is the National Medical Director of the Parkinson's Foundation, the country's largest Parkinson's disease patient and advocacy group. Michael is a prolific writer with over 500 publications and the author of the book, Parkinson's Treatment: 10 Secrets to a Better Life, that has been translated into 20 languages and is a bestseller for patients and families.
Bastiaan Bloem is a Professor of Neurology and the Medical Director at Radboud University Nijmegen Medical Centre in the Netherlands. In 2004, with Dr. Marten Munneke, Bas created ParkinsonNet, the largest integrated care program for Parkinson's patients. He is an Associate Editor of the Journal of Parkinson's Disease, and has been a featured speaker at leading patient, academic, and health conferences globally.
Table of Contents
Note to Readers ix
Part 1 A Formidable Disease
1 Six Men in London: The Discovery of a New Disease and Its Causes 11
2 A Man-Made Pandemic: How Chemicals Have Fueled the Onslaught 31
3 Vanquishing Indifference: Lessons from the Fights Against Polio, HIV/AIDS, and Breast Cancer 45
Part 2 The Pact-Preventing, Advocating, Caring, and Treating
4 Before It Starts: The Urgency of Banning Specific Pesticides to Lower Our Risk 65
5 Cleaning Up: How Solvents and Contaminated Groundwater Spread the Disease 83
6 Protecting Ourselves: The Role of Head Trauma, Exercise, and Diet 97
7 Taking Care: Helping Those Who Bear the Parkinson's Burden 109
8 Hope on the Horizon: The Promise of New Treatments 131
9 Taking Charge: The Policies and Research Funding We Need 147
Part 3 A Prescription for Action
10 Within Our Reach: How We Can End Parkinson's 169
A Prescription for Action 190